Latest news with #KingFaisalSpecialistHospital&ResearchCentre
Mid East Info
2 days ago
- Business
- Mid East Info
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region - Middle East Business News and Information
As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Business Upturn
2 days ago
- Business
- Business Upturn
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region
RIYADH, Saudi Arabia, June 04, 2025 (GLOBE NEWSWIRE) — As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at [email protected]. A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Yahoo
2 days ago
- Business
- Yahoo
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region
KFSHRC accounts for 52.4% of all active clinical trials in Saudi Arabia. RIYADH, Saudi Arabia, June 04, 2025 (GLOBE NEWSWIRE) -- As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@ A photo accompanying this announcement is available at
Mid East Info
27-05-2025
- Business
- Mid East Info
KFSHRC's 3D Medical Printing: Faster Surgeries, Fewer Complications
Riyadh: King Faisal Specialist Hospital & Research Centre (KFSHRC) has earned ISO 13485:2016 certification for its 3D Printing Services Department. This ISO certification represents the highest global standards for quality management systems in the design and manufacture of medical devices. It reflects the KFSHRC's strength in delivering innovative, custom-made solutions in complex clinical settings with rigorous quality control and assurance. KFSHRC's 3D Printing Services Department has become a cornerstone of the hospital's precision healthcare ecosystem. The department uses advanced additive manufacturing to produce patient-specific anatomical models, surgical guides, prosthetics and implants to improve surgical planning, reduce intraoperative risks, and augment clinical outcomes. In 2023, the department produced over 1,100 physical models and more than 5,000 digital simulations, which shortened average surgery time by 30% and reduced complications by 85%, significantly improving patient satisfaction. KFSHRC's achievements in this field have also garnered international recognition. The hospital was ranked among the top 20 Saudi government entities in the Emerging Technology Adoption Readiness Index for 2025. The Global Project Management Forum (GPMF) awarded its 3D Printing Project the 2024 Global Excellence Award in Technology Project Management. 'Our mission is to conduct cutting-edge, multidisciplinary research and integrate the innovative technologies into medical practice. Our expertise in 3D printing, artificial intelligence and robotics is combined to advance healthcare delivery. We are expanding our technology platforms and working towards our Kingdom's Vision 2030 to spin off a 3D printing medical technology company that would provide a broad healthtech and socioeconomic impact.' Notably, for the third consecutive year, KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres. According to the 2025 Brand Finance rankings, it has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East. Additionally, it was included in Newsweek magazine's World's Best Smart Hospitals list for 2025.
Newsweek
30-04-2025
- Health
- Newsweek
Robotics in Health Care: A New Era of Precision and Possibility
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The future of health care is unfolding before our eyes, driven by an unprecedented fusion of robotics and artificial intelligence (AI). What was once speculative technology is now steadily reshaping patient care. Enhanced surgical precision and reduced complications are making lifesaving interventions more accessible. With global spending on surgical robotics projected to exceed $20.98 billion by 2030, and the AI health care market expected to reach $187 billion in the same year, advanced automation has transitioned from "nice to have" to an essential driver of modern medicine. Throughout the Middle East and beyond, health care institutions increasingly rely on robotic-assisted surgery, AI-powered diagnostics and intelligent hospital automation to enhance clinical outcomes and optimize operational efficiencies. From streamlined diagnostic workflows to predictive hospital management, robotics is rapidly altering the way care is delivered. This shift is exemplified by King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia, a global leader in using robotics to enhance patient care and operational efficiency. King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia is a global leader in using robotics to enhance patient care and operational efficiency. King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia is a global leader in using robotics to enhance patient care and operational efficiency. King Faisal Specialist Hospital & Research Centre Historically, cardiac procedures like heart transplants and artificial heart pump implantations were high-risk interventions requiring prolonged hospital stays. Now, fully robotic heart transplants can be completed in just 2.5 hours, substantially improving surgical efficiency and patient recovery. Likewise, the robotic-assisted implantation of the HeartMate 3 artificial heart pump has cut ICU stays from an average of 26 days to only four, dramatically reducing complications and redefining outcomes for patients once faced with daunting recovery paths. Yet, cardiac surgery is only one part of this larger transformation. Robotic systems are now advancing liver transplantation, neurosurgery and pediatric care, delivering unmatched precision in even the most complex medical interventions. Fully robotic liver transplantations, for example, illustrate how robotics can replace highly invasive methods, dramatically reducing post-operative complications and recovery times. Other breakthroughs, such as robotic-assisted pancreas transplants and retroperitoneal lymph node dissection, further demonstrate how robotic precision is making once-challenging surgeries safer and more successful. At KFSHRC alone, 1,127 robotic-assisted procedures were completed in 2024, underscoring how this approach has rapidly moved from a futuristic concept to a transformative reality in daily practice. Neurosurgical robotics similarly enhances the accuracy of brain and spinal procedures, minimizing human error in operations that demand sub-millimeter precision. Meanwhile, AI-powered soft robotics allows for highly flexible, adaptive instruments that reduce trauma during intricate interventions. Collectively, these developments point to robotics as a new standard of care—one that delivers superior outcomes for patients facing a wide range of serious conditions. The synergy of AI and robotics is also ushering in predictive, personalized medicine. AI-powered diagnostic tools deliver results 20 percent faster, improving pre-surgical planning and reducing human errors, while real-time analytics allow robotic systems to adapt mid-operation for unprecedented responsiveness. Concurrently, AI-driven virtual pathology services enhance diagnostic accuracy and free specialists to address the most complex cases. By integrating these capabilities, medicine is shifting from reactive to proactive, preventing complications before they arise and tailoring treatment to each patient's unique genetic and physiological profile. Robotic surgeries often have better outcomes for the patient including shorter recovery times. Robotic surgeries often have better outcomes for the patient including shorter recovery times. King Faisal Specialist Hospital and Research Centre Robotics are also transforming rehabilitation and physical therapy, where exoskeletons and AI-driven prosthetics are helping patients recover mobility with greater speed and effectiveness. Hospitals are integrating robotic automation in pharmacy management and supply chain logistics, improving medication dispensing accuracy and ensuring consistent inventory flow. These system-wide optimizations not only elevate patient safety but also reduce operational expenses, enabling health care providers to redirect resources where they are needed most. Another exciting frontier in robotic health care is nanomedicine, where microscopic robots are being developed to target cancerous cells, deliver drugs with extreme precision and even repair tissues at a cellular level. For instance, nanorobots smaller than blood cells are being designed to deliver medication directly to tumor sites, potentially revolutionizing cancer treatment by reducing severe side effects associated with traditional chemotherapy. This concept of "intelligent drug delivery" has shown promising results in preclinical trials, indicating a future where nanorobots could become integral to cancer treatment protocols. Simultaneously, the emergence of smart hospitals—digitized ecosystems integrating AI, IoT and robotic automation—is rapidly reshaping global health care delivery. With the global smart hospital market projected to reach $148 billion by 2029, hospitals worldwide are adopting technologies such as AI-powered virtual nursing assistants, robotic patient transport systems and automated drug administration systems, significantly enhancing hospital workflows and patient experiences. These digitized environments, characterized by centralized electronic health records (EHRs), automated patient monitoring and real-time data analytics, significantly enhance resource allocation and patient care delivery efficiency. Saudi Arabia has notably invested approximately $1.5 billion in digital health infrastructure, emphasizing the development of centralized EHRs, telemedicine capabilities and advanced analytics, which collectively drive greater efficiency and elevate health care standards across the nation, positioning Saudi Arabia among global leaders in smart health care innovation. Beyond clinical innovation, robotic-assisted surgery is making top-tier health care more accessible and cost-effective. In many medical centers, the cost of heart transplants has fallen by 40 percent compared to Western averages, boosting affordability without sacrificing quality. As medical tourism hubs adopt robotics, international patients gain access to advanced surgeries at lower costs, contributing to a 50 percent reduction in hospital stays, proven cost efficiency and patient satisfaction rates climbing to 92 percent. At KFSHRC alone, 1,127 robotic-assisted procedures were completed in 2024. At KFSHRC alone, 1,127 robotic-assisted procedures were completed in 2024. King Faisal Specialist Hospital & Research Centre As health care enters this new era, robotics and AI are poised to become cornerstones of modern medicine. However, responsible implementation is essential. Hospitals must ensure robotic technologies enhance—not replace—human expertise, bolstered by robust ethical frameworks and clear accountability measures. Equally vital is ongoing workforce development through structured training, simulation-based exercises and cross-disciplinary workshops. The Kingdom has taken a proactive stance, investing in AI training, medical education and simulation-based surgical programs. Through the Human Capability Development Program (HCDP) and expanded digital health certifications, the Kingdom is preparing its health care workforce for the future. This approach—combining infrastructure investment with human capability development positions Saudi Arabia as a leader in the future of AI-driven health care. Ultimately, in the race to health care robotics, success will be judged not by the sheer number of procedures performed, but by the lives saved. It falls to health care leaders to guide this transformation, ensuring that these remarkable innovations transcend technological achievement to truly improve lives and elevate the global standard of care. H.E. Dr. Majid Al Fayyadh is a member of the Newsweek CEO Circle, an invite-only executive community of subscribers.
